0000905148-24-000969.txt : 20240318 0000905148-24-000969.hdr.sgml : 20240318 20240318162457 ACCESSION NUMBER: 0000905148-24-000969 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240315 FILED AS OF DATE: 20240318 DATE AS OF CHANGE: 20240318 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sullivan Amy CENTRAL INDEX KEY: 0001887865 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41008 FILM NUMBER: 24759377 MAIL ADDRESS: STREET 1: 38 OUTLOOK ROAD CITY: SWAMPSCOTT STATE: MA ZIP: 01907 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IO Biotech, Inc. CENTRAL INDEX KEY: 0001865494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 870909276 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: OLE MAALOES VEH 3 CITY: COPENHAGEN STATE: G7 ZIP: 2200 BUSINESS PHONE: 4570702980 MAIL ADDRESS: STREET 1: OLE MAALOES VEH 3 CITY: COPENHAGEN STATE: G7 ZIP: 2200 4 1 form4.xml X0508 4 2024-03-15 0001865494 IO Biotech, Inc. IOBT 0001887865 Sullivan Amy C/O IO BIOTECH, INC. OLE MAALOES VEJ 3 COPENHAGEN G7 2200 DENMARK true Chief Financial Officer false Stock Option (Right to Buy) 1.65 2024-03-15 4 A 0 280000 0 A 2034-03-15 Common Stock 280000 280000 D One-fourth of these options vest on March 15, 2025, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control. /s/ Brian Burkavage, Attorney-in-Fact for Amy Sullivan 2024-03-18